Clinical Trials
17
Active:1
Completed:9
Trial Phases
4 Phases
Early Phase 1:1
Phase 3:1
Phase 4:1
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials
Not Applicable
7 (70.0%)Early Phase 1
1 (10.0%)Phase 3
1 (10.0%)Phase 4
1 (10.0%)Utilization of the Viracor® Assay for Valganciclovir Prophylaxis in CMV High Risk Kidney Transplant Recipients
- First Posted Date
- 2022-02-14
- Last Posted Date
- 2024-11-12
- Lead Sponsor
- Piedmont Healthcare
- Target Recruit Count
- 37
- Registration Number
- NCT05238220
- Locations
- 🇺🇸
Piedmont Atlanta Hospital, Atlanta, Georgia, United States
Efficacy of Aldosterone Antagonist Therapy for Prevention of New Atrial Fibrillation
Early Phase 1
Active, not recruiting
- Conditions
- AFib
- Interventions
- First Posted Date
- 2019-04-29
- Last Posted Date
- 2025-05-29
- Lead Sponsor
- Piedmont Healthcare
- Target Recruit Count
- 50
- Registration Number
- NCT03929718
- Locations
- 🇺🇸
Piedmont Heart Institute, Atlanta, Georgia, United States
ULTRAsound-assisted Catheter vs. STAndaRd Catheter Thrombolysis for Submassive Pulmonary Embolism
Not Applicable
Completed
- Conditions
- Submassive Pulmonary Embolism
- First Posted Date
- 2018-01-04
- Last Posted Date
- 2021-09-24
- Lead Sponsor
- Piedmont Healthcare
- Target Recruit Count
- 10
- Registration Number
- NCT03389971
- Locations
- 🇺🇸
Piedmont Healthcare, Atlanta, Georgia, United States
In-hospital and Long-term Outcomes for Percutaneous Chronic Total Coronary Occlusion Revascularization in a High-volume, Multi-operator Program
Completed
- Conditions
- Ischemic Heart Disease
- First Posted Date
- 2013-09-20
- Last Posted Date
- 2019-04-02
- Lead Sponsor
- Piedmont Healthcare
- Target Recruit Count
- 500
- Registration Number
- NCT01946724
- Locations
- 🇺🇸
Piedmont Heart Institute, Atlanta, Georgia, United States
Contribution of Hepatic and Intestinal Lipoproteins to Human Atherosclerosis
Withdrawn
- Conditions
- Heart Disease
- First Posted Date
- 2011-03-23
- Last Posted Date
- 2013-09-05
- Lead Sponsor
- Piedmont Healthcare
- Registration Number
- NCT01321476
- Prev
- 1
- 2
- 3
- 4
- Next
News
Novel Radiotherapy Approaches Show Promise in Limited-Stage Small Cell Lung Cancer Treatment
Recent clinical evidence has established that both once-daily and twice-daily radiotherapy regimens show comparable efficacy in limited-stage small cell lung cancer treatment, eliminating the need for further fractionation studies.